Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

Clinical trial NCT00588536 · COMPLETED

Trial details

NCT number: NCT00588536
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Langerhans Cell Histiocytosis

Start date: 1995-01-01
Primary completion: 2008-07-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.